iXensor Past Earnings Performance
Past criteria checks 0/6
iXensor has been growing earnings at an average annual rate of 30.8%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 55.7% per year.
Key information
30.8%
Earnings growth rate
33.5%
EPS growth rate
Medical Equipment Industry Growth | 11.5% |
Revenue growth rate | 55.7% |
Return on equity | -111.1% |
Net Margin | -138.4% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How iXensor makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 37 | -52 | 38 | 26 |
31 Mar 23 | 71 | -28 | 39 | 27 |
31 Dec 22 | 105 | -5 | 40 | 28 |
30 Sep 22 | 101 | -8 | 41 | 27 |
30 Jun 22 | 97 | -11 | 42 | 26 |
31 Mar 22 | 61 | -42 | 40 | 37 |
31 Dec 21 | 25 | -73 | 39 | 47 |
30 Sep 21 | 19 | -81 | 41 | 52 |
30 Jun 21 | 14 | -90 | 43 | 56 |
31 Mar 21 | 15 | -83 | 46 | 46 |
31 Dec 20 | 16 | -77 | 48 | 36 |
30 Sep 20 | 19 | -88 | 60 | 37 |
30 Jun 20 | 22 | -99 | 71 | 39 |
31 Mar 20 | 26 | -102 | 73 | 40 |
31 Dec 19 | 30 | -105 | 76 | 42 |
30 Sep 19 | 27 | -103 | 66 | 47 |
30 Jun 19 | 24 | -101 | 57 | 51 |
31 Mar 19 | 18 | -104 | 55 | 54 |
31 Dec 18 | 11 | -108 | 53 | 57 |
31 Dec 17 | 15 | -108 | 48 | 70 |
31 Dec 16 | 0 | -95 | 32 | 74 |
Quality Earnings: 6734 is currently unprofitable.
Growing Profit Margin: 6734 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6734 is unprofitable, but has reduced losses over the past 5 years at a rate of 30.8% per year.
Accelerating Growth: Unable to compare 6734's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6734 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-17.2%).
Return on Equity
High ROE: 6734 has a negative Return on Equity (-111.09%), as it is currently unprofitable.